Piper Sandler raised the firm’s price target on Solventum (SOLV) to $84 from $75 and keeps a Neutral rating on the shares. The firm notes reported Q4 results that included revenue and EPS that came in above consensus as the Solventum team extends its early track record of quarterly beats.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SOLV:
- Solventum Corporation Reports Strong Q4 2024 Results
- Solventum reports Q4 EPS $1.41, consensus $1.31
- Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $6.59
- Cautious Hold Rating on Solventum Corporation Amid Strategic Sale and Debt Uncertainties
- Trian ‘commends’ Solventum on Filtration unit sale, sees cost cut opportunities